Table IV.
Parameters | E-AED I group | E-AED II group | P-value |
---|---|---|---|
NREM phase 1 (min) | 29.50±10.61 | 92.10±48.24 | <0.05 |
REM phase (min) | 116.99±12.90 | 70.82±17.69 | <0.05 |
Sleep efficiency (min) | 91.96±3.14 | 89.39±2.55 | <0.05 |
Times the patient awoke (n) | 2.40±1.39 | 7.25±2.86 | <0.05 |
Periods of REM (n) | 4.45±0.999 | 3.60±0.995 | <0.05 |
Data are expressed as the mean ± SD. E-AED I, duration of VPA administration <3 months; E-AED II, duration of VPA administration >3 months; VPA, sodium valproate; NREM, non-rapid eye movement; REM, rapid eye movement.